RIBAVIRIN Safety Questions, RIBAVIRIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RIBAVIRIN. Our extensive database of RIBAVIRIN adverse events and RIBAVIRIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RIBAVIRIN
RIBAVIRIN Safety Reports
Total RIBAVIRIN reports: 164.RIBAVIRIN FDA safety alerts: 2002 .
Reported deaths: 13 Reported hospitalizations: 73.
Take RIBAVIRIN Side Effects Survey or Share Your RIBAVIRIN Story. RIBAVIRIN Usage.
Showing 1-75 of 164 Next >
Physician from UNITED STATES reported RIBAVIRIN problem on July 11, 2006. Male patient, 65 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: ascites, asthenia, disturbance in attention, hepatic cirrhosis, lethargy, oral intake reduced, urinary tract infection. RIBAVIRIN dosage: unknown. During the same period patient was treated with INTERFERON ALFACON, BISOPROLOL FUMARATE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.RIBAVIRIN problem was reported by a Pharmacist from UNITED STATES on Aug 07, 2006. Male patient, 50 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: ocular toxicity, visual disturbance, visual field defect. RIBAVIRIN dosage: 600 MG BID PO. During the same period patient was treated with PEGASYS. Patient recovered.
Physician from UNITED STATES reported RIBAVIRIN problem on July 20, 2006. Female patient was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: premature baby. RIBAVIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, encephalitis, liver disorder, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported RIBAVIRIN problem on July 31, 2006. Female patient, 36 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: gastric disorder, rosacea. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Aug 07, 2006. Male patient, 49 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. RIBAVIRIN dosage: 1200 MG QD ORAL. During the same period patient was treated with INFERGEN. Patient died on 01/01/2006.
Health Professional from UNITED STATES reported RIBAVIRIN problem on Aug 17, 2006. Female patient, 54 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: aphasia, liver function test abnormal, transient ischaemic attack. RIBAVIRIN dosage: 800 MG ORAL. During the same period patient was treated with INFERGEN, PROCRIT. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Female patient, 57 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: aggression, anxiety, feeling abnormal, homicidal ideation, irritability. RIBAVIRIN dosage: 400 MILLIGRAM BID ORAL. During the same period patient was treated with PEGASYS, LISINOPRIL, ACTOS, GLYBURIDE. Patient recovered.
Health Professional from UNITED STATES reported RIBAVIRIN problem on July 13, 2005. Female patient, 70 years of age, weighting 140.0 lb, was diagnosed with hepatitis c, crohn's disease and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia. RIBAVIRIN dosage: 1000 MG QD ORAL. During the same period patient was treated with REMICADE, ASACOL, INSULIN, DOXEPIN, EYE DROPS, MERCAPTOPURINE, PEGASYS, FOLIC ACID. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 46 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation, viral load increased, white blood cell count decreased. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS. Patient recovered.
Health Professional from UNITED STATES reported RIBAVIRIN problem on Jan 25, 2006. Female patient, 43 years of age, weighting 222.0 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia. RIBAVIRIN dosage: 1200-400MG*QD ORAL. During the same period patient was treated with INFERGEN, OXCARBAZEPINE, TOPAMAX, LAMOTRIGINE, TRAZODONE. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Mar 10, 2006. Female patient, 55 years of age, weighting 120.2 lb, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, dyspnoea, pyrexia, rash. RIBAVIRIN dosage: unknown. During the same period patient was treated with HYDROXYZINE, SINGULAIR, CELEXA, COMBIVENT, FLONASE, ADVAIR DISKUS, MEDROL. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported RIBAVIRIN problem on Aug 31, 2006. Male patient, 53 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: appetite disorder, condition aggravated, depression, fatigue, irritability, schizoaffective disorder, stress. RIBAVIRIN dosage: 400 MG, BID, ORAL. During the same period patient was treated with PEGINTERFERON, METHADONE, OLANZAPINE, SERTRALINE. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from ITALY on Sept 01, 2006. Male patient, 53 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anuria, arterial occlusive disease, arteritis, ascites, hepatic failure, hepatorenal syndrome, intestinal haemorrhage, intestinal ischaemia, jejunitis. RIBAVIRIN dosage: 1000 MG, QD, UNK. Patient was hospitalized. Patient died.
Consumer or non-health professional from FRANCE reported RIBAVIRIN problem on Aug 24, 2006. Male patient, 30 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, depression, immunoglobulins increased. RIBAVIRIN dosage: 1000 MG, QD,. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient recovered.
RIBAVIRIN problem was reported by a Physician from SPAIN on Apr 29, 2005. Female patient, 45 years of age, weighting 116.8 lb, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, oedema, pruritus. RIBAVIRIN dosage: unknown. During the same period patient was treated with EBASTEL, ATARAX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: amnesia, encephalitis, feeling abnormal, reaction to preservatives, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: encephalitis, hypersensitivity, loss of consciousness, reaction to preservatives, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: 400MG BID ORAL. During the same period patient was treated with AVINZA, ZANAFLEX, EFFEXOR, AMBIEN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported RIBAVIRIN problem on Sept 15, 2006. Male patient, 53 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, schizophrenia, suicide attempt, treatment noncompliance. RIBAVIRIN dosage: 1000 MG QDAY PO. During the same period patient was treated with PEGASYS, RISPERDAL, COGENTIN, TRAZODONE. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2006. Female patient, 46 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, asthenia, dehydration, fatigue, nausea, white blood cell count decreased. RIBAVIRIN dosage: 400 MG BID PO. During the same period patient was treated with PEGASYS, LEXAPRO. Patient recovered.
Health Professional from UNITED STATES reported RIBAVIRIN problem on Sept 05, 2006. Male patient, 21 years of age, was diagnosed with hepatitis c, thrombocytopenia and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anaemia, cardiac failure, encephalopathy, haemoglobin decreased, infection, multi-organ failure, neutropenia. RIBAVIRIN dosage: unknown. During the same period patient was treated with INTERKEUKIN. Patient died.
RIBAVIRIN problem was reported by a Health Professional from UNITED STATES on Sept 19, 2006. Female patient, 54 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, transient ischaemic attack. RIBAVIRIN dosage: 800 MG; PO. During the same period patient was treated with INFERGEN, PROCTIR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on June 26, 2006. Female patient, 57 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: aggression, anxiety, feeling abnormal, homicidal ideation, irritability. RIBAVIRIN dosage: 400 MILLIGRAM BID ORAL. During the same period patient was treated with PEGASYS, LISINOPRIL, ACTOS, GLYBURIDE. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 51 years of age, weighting 151.9 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, blood pressure increased, chest discomfort, chest pain, constipation, crying, depression. RIBAVIRIN dosage: 1000 MG QDAY PO. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Sept 22, 2006. Male patient, 51 years of age, weighting 151.9 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, blood pressure increased, chest discomfort, chest pain, condition aggravated, constipation, crying, depression. RIBAVIRIN dosage: 1000 MG QDAY PO. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 51 years of age, weighting 151.9 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure increased, chest pain, constipation, crying, depression, labyrinthitis, middle insomnia. RIBAVIRIN dosage: 1000 MG QDAY PO. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Sept 25, 2006. Female patient, 53 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, fall, gout, renal failure acute, urinary tract infection. RIBAVIRIN dosage: 1200 MG QDAY PO. During the same period patient was treated with PEGASYS, PROZAC, KLONOPIN, SEROQUEL, ADDERALL, NEXIUM. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Health Professional from UNITED STATES on Oct 04, 2006. Female patient, weighting 6.83 lb, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: dacryostenosis congenital, eye discharge, jaundice neonatal, neonatal disorder, normal newborn, oral candidiasis. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.
Physician from UNITED STATES reported RIBAVIRIN problem on Oct 11, 2006. Female patient, 56 years of age, weighting 227.0 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Health Professional from UNITED STATES on Oct 17, 2006. Female patient, 37 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, nasopharyngitis, pregnancy of partner. RIBAVIRIN dosage: 600MG - BID - ORAL. During the same period patient was treated with PEGASYS, ROBITUSSIN, PRENATAL VITAMINS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Oct 27, 2006. Male patient, 60 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, melaena, rectal haemorrhage. RIBAVIRIN dosage: 400MG PO QAM AND 600MG QPM. During the same period patient was treated with ALBUTEROL, ASPIRIN, ATENOLOL, CITALOPRAM HYDROBROMIDE, PLAVIX, EPOETIN, ETODOLAC, FOLIC ACID. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2006. Female patient, 57 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: dreamy state, hallucination, unevaluable event. RIBAVIRIN dosage: unknown. During the same period patient was treated with ZYPREXA. Patient recovered.
Physician from UNITED STATES reported RIBAVIRIN problem on July 11, 2006. Female patient, weighting 144.0 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, leukopenia. RIBAVIRIN dosage: 200 MILLIGRAM QID ORAL. During the same period patient was treated with PEGASYS, BONIVA, CALCIUM, VITAMINS NOS, ASCORBIC ACID, COENZYME Q, VITAMIN E, FIORICET. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Mar 10, 2006. Female patient, 55 years of age, weighting 120.2 lb, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood glucose increased, chest pain, chronic obstructive pulmonary disease, dyspnoea, emphysema, hepatitis c, pyrexia, rash. RIBAVIRIN dosage: unknown. During the same period patient was treated with HYDROXYZINE, SINGULAIR, CELEXA, COMBIVENT, FLONASE, ADVAIR HFA, MEDROL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported RIBAVIRIN problem on Oct 17, 2006. Female patient, 37 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: nasopharyngitis, pregnancy of partner. RIBAVIRIN dosage: 600 MG BID ORAL. During the same period patient was treated with PEGASYS, ROBITUSSIN, PRENATAL VITAMINS. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: encephalitis, hypersensitivity, reaction to preservatives, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, encephalitis, loss of consciousness. RIBAVIRIN dosage: 400 MG BID ORAL. During the same period patient was treated with AVINZA, ZANAFLEX, EFFEXOR, AMBIEN. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 46 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, asthenia, dehydration, nausea, neutrophil count decreased, red blood cell count decreased, white blood cell count decreased. RIBAVIRIN dosage: 400 MG BID PO. During the same period patient was treated with PEGASYS, LEXAPRO. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported RIBAVIRIN problem on Nov 03, 2006. Male patient, 70 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: gynaecomastia, pruritus. RIBAVIRIN dosage: unknown. During the same period patient was treated with VIRAFERONPEG, AMLODIPINE, ATENOLOL. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2006. Male patient was diagnosed with hepatitis c, insomnia and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: fatigue, hangover, memory impairment, mental impairment, rebound effect, road traffic accident. RIBAVIRIN dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE, ASPIRIN, AMBIEN, PROCRIT. Patient recovered.
Physician from CANADA reported RIBAVIRIN problem on Oct 25, 2006. Female patient, 42 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: choroidal neovascularisation, cytomegalovirus antibody positive, eye haemorrhage, hepatic fibrosis, retinopathy, viraemia, visual acuity reduced, visual disturbance. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient, 53 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, fall, gout, renal failure acute, urinary tract infection. RIBAVIRIN dosage: 1200 MG QDAY PO. During the same period patient was treated with PEGASYS, PROZAC, KLONOPIN, SEROQUEL, ADDERALL, NEXIUM. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported RIBAVIRIN problem on Nov 14, 2006. Female patient, 50 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: blood blister. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Sept 25, 2006. Male patient, 45 years of age, weighting 157.0 lb, was diagnosed with hepatitis c, anaemia and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, antiphospholipid syndrome, aplasia pure red cell, cerebrovascular accident, haemolysis, transfusion reaction. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS, PROCRIT, COUMADIN, FOLIC ACID, LOVASTATIN. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported RIBAVIRIN problem on Nov 21, 2006. Female patient, 50 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: blood blister. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, encephalitis, feeling abnormal, hypersensitivity, respiratory distress, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported RIBAVIRIN problem on Dec 04, 2006. Female patient, 52 years of age, weighting 140.0 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, hepatitis c, hyperlipidaemia, hypertension. RIBAVIRIN dosage: 800MG QD PO. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Nov 27, 2006. Female patient, 60 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, haemolysis, hepatic enzyme increased. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient died on 11/01/2006.
Consumer or non-health professional from UNITED KINGDOM reported RIBAVIRIN problem on Dec 04, 2006. Male patient, weighting 213.8 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: porphyria. RIBAVIRIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, VIRAFERONPEG. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Health Professional from UNITED KINGDOM on Nov 30, 2006. Male patient, 66 years of age, was diagnosed with respiratory syncytial virus infection and was treated with RIBAVIRIN. RIBAVIRIN dosage: unknown. Patient died on 01/12/2006.
Health Professional from UNITED KINGDOM reported RIBAVIRIN problem on Dec 05, 2006. Male patient, weighting 213.8 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: porphyria. RIBAVIRIN dosage: 600 MG; BID; PO. During the same period patient was treated with VIRAFERONPEG, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Nov 07, 2006. Male patient, weighting 229.1 lb, was diagnosed with hepatitis c, insomnia and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: fatigue, hangover, memory impairment, mental impairment, rebound effect, road traffic accident. RIBAVIRIN dosage: unknown. During the same period patient was treated with METFORMIN, GLYBURIDE, ASPIRIN, AMBIEN, PROCRIT, GLIPIZIDE, EFFEXOR. Patient recovered.
Physician from BRAZIL reported RIBAVIRIN problem on Dec 15, 2006. Male patient, 44 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, idiopathic thrombocytopenic purpura. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Physician from BRAZIL on Dec 15, 2006. Male patient, 44 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, idiopathic thrombocytopenic purpura. RIBAVIRIN dosage: unknown. Patient recovered.
Physician from BRAZIL reported RIBAVIRIN problem on Dec 15, 2006. Male patient, 44 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, idiopathic thrombocytopenic purpura, nephropathy toxic. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Physician from BRAZIL on Dec 15, 2006. Male patient, 44 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, fatigue, focal glomerulosclerosis, haematuria, idiopathic thrombocytopenic purpura, joint swelling, nephropathy toxic, proteinuria. RIBAVIRIN dosage: unknown. Patient recovered.
Physician from CANADA reported RIBAVIRIN problem on Dec 07, 2006. Male patient, 44 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, fatigue, haemorrhoids, influenza like illness, insomnia, leukopenia, normochromic normocytic anaemia, rectal haemorrhage, thrombocytopenia. RIBAVIRIN dosage: 500 MG, BID,. During the same period patient was treated with PEGASYS. Patient recovered.
RIBAVIRIN problem was reported by a Health Professional from UNITED KINGDOM on Dec 05, 2006. Male patient, weighting 213.8 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: porphyria. RIBAVIRIN dosage: 600 MG;BID;PO. During the same period patient was treated with VIRAFERONPEG, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported RIBAVIRIN problem on Nov 30, 2006. Male patient, 66 years of age, was diagnosed with respiratory syncytial virus infection and was treated with RIBAVIRIN. RIBAVIRIN dosage: unknown. Patient died on 01/12/2006.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 56 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: amnesia, encephalitis, loss of consciousness, reversible posterior leukoencephalopathy syndrome. RIBAVIRIN dosage: 400MG - BID - ORAL. During the same period patient was treated with AVINZA, ZANAFLEX, EFFEXOR, AMBIEN, OXYCONTIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported RIBAVIRIN problem on Dec 22, 2006. Female patient, 52 years of age, weighting 110.0 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia. RIBAVIRIN dosage: 600 MG; 400 MG EVERY AM; EVERY PM PO. During the same period patient was treated with PEGASYS. Patient recovered.
RIBAVIRIN problem was reported by a Pharmacist from UNITED STATES on Dec 22, 2006. Male patient, 58 years of age, weighting 175.7 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia. RIBAVIRIN dosage: 400 MG TWICE DAILY PO. During the same period patient was treated with PEGINTERON ALPHA. Patient recovered.
Consumer or non-health professional from SPAIN reported RIBAVIRIN problem on Dec 13, 2006. Female patient, 35 years of age, was diagnosed with hepatitis c virus and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-platelet antibody positive, antinuclear antibody positive, haemoglobin decreased, haemorrhagic diathesis, idiopathic thrombocytopenic purpura, leukopenia, metrorrhagia, petechiae. RIBAVIRIN dosage: 1200 MG, QD; SEE IMAGE. During the same period patient was treated with PPEGINTERFERON ALFA. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Health Professional from BRAZIL on Dec 13, 2006. Male patient, 49 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, autoantibody positive, disease recurrence, fatigue, gamma-glutamyltransferase increased, hepatitis c virus, liver disorder, viral infection. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.
Health Professional from BRAZIL reported RIBAVIRIN problem on Dec 13, 2006. Male patient, 52 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, antibody test positive, arthralgia, gamma-glutamyltransferase increased, immunoglobulins increased, liver disorder, pruritus, thrombocytopenia. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.
RIBAVIRIN problem was reported by a Physician from BRAZIL on Dec 13, 2006. Male patient, 62 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, autoantibody positive, autoimmune disorder, fatigue, neutropenia, thrombocytopenia. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGINTERFERON ALFA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Dec 18, 2006. Female patient, 46 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, asthenia, dehydration, dysstasia, fatigue, nausea, neutrophil count decreased, white blood cell count decreased. RIBAVIRIN dosage: 400 MG BID PO. During the same period patient was treated with PEGASYS, LEXAPRO, PROCRIT. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Female patient, 50 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: anaemia, dizziness, fall. RIBAVIRIN dosage: 1200 MG QDAY PO. During the same period patient was treated with PEGASYS. Patient recovered.
Physician from GERMANY reported RIBAVIRIN problem on June 29, 2007. Male patient, 43 years of age, weighting 180.8 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: schizoaffective disorder. RIBAVIRIN dosage: unknown. During the same period patient was treated with SUBUTEX. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2007. Female patient was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abortion induced. RIBAVIRIN dosage: 400MG BID. During the same period patient was treated with PEGASYS. Patient recovered.
Physician from GERMANY reported RIBAVIRIN problem on July 23, 2007. Male patient, 43 years of age, weighting 180.8 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: schizoaffective disorder. RIBAVIRIN dosage: unknown. During the same period patient was treated with SUBUTEX. Patient was hospitalized. Patient recovered.
RIBAVIRIN problem was reported by a Physician from PUERTO RICO on July 19, 2007. Male patient, 48 years of age, weighting 149.0 lb, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: haemorrhagic anaemia. RIBAVIRIN dosage: unknown. During the same period patient was treated with FIBER NOS, ANALPRAM, HEMATRON, METAMUCIL, SYNTHROID. Patient recovered.
Physician from BELGIUM reported RIBAVIRIN problem on July 19, 2007. Female patient, 49 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, influenza like illness, myalgia, pyrexia, somatic delusion. RIBAVIRIN dosage: unknown. Patient recovered.
RIBAVIRIN problem was reported by a Physician from UNITED STATES on Mar 27, 2007. Female patient was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Aug 10, 2006. Female patient, 52 years of age, was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis. RIBAVIRIN dosage: unknown. Patient recovered.
Showing 1-75 of 164 Next >
This
drug has an active FDA Safety Alert